Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunological Characteristics of COVID-19 Patients and Determination of Neutralizing Antibodies Against SARS-CoV-2 Virus

NCT04679428 is registered in ClinicalTrials.gov with The University Clinic of Pulmonary and Allergic Diseases Golnik as lead sponsor.

NCT NCT04679428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04679428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunological Characteristics of COVID-19 Patients and Determination of Neutralizing Antibodies Against SARS-CoV-2 Virus
Lead sponsor
The University Clinic of Pulmonary and Allergic Diseases Golnik
Phase
Observational
Overall status
Unknown status
Start date
May 7, 2020
Completion date
May 7, 2023
Enrollment
230 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19